Antoaneta A. Andonova

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The mechanistic target of rapamycin (mTOR) controls cell growth and enlargement and has been found to be aberrant in a wide variety of malignancies. Although mTOR is already an attractive antineoplastic target, overexpression or aberrant expression of mTOR may also provide an opportunity to further increase the size differential between malignant and normal(More)
  • 1